Bid Price | 155.00p | High Price | 170.00p |
---|
Ask Price | 170.00p | Low Price | 155.75p |
---|
Open Price | 165.00p | Spread | 8.82% |
---|
Prev Close | 165.00p | Volume | 8,759 |
---|
Faron Pharmaceuticals Oy Historic Prices
Date | Open | High | Low | Close | Volume |
---|
Nov 11, 2024 | 155.00 | 170.00 | 150.05 | 165.00 | 4,982 |
Nov 8, 2024 | 152.50 | 154.90 | 151.10 | 152.50 | 2,230 |
Nov 7, 2024 | 157.50 | 160.00 | 145.00 | 152.50 | 27,114 |
Nov 6, 2024 | 157.50 | 160.00 | 155.00 | 157.50 | 1,652 |
Nov 5, 2024 | 165.00 | 160.00 | 155.00 | 156.00 | 63,019 |
More Faron Pharmaceuticals Oy Historic Prices >Faron Pharmaceuticals Oy Information
Name | Faron Pharmaceuticals Oy | Index | FTSE AIM 100 |
---|
ISIN | FI4000153309 | Epic | FARN |
---|
Type | Equity | Currency | GBX |
---|
Record Status | Active | Trading Segment | ASQ1 |
---|
Industry | Biotechnology | Sector | Healthcare |
---|
EMS | 750 | Trading Status | Closed |
---|
Shares in Issue | 104.62 m | Prev Close | 165.00p |
---|
PE Ratio | | Market Cap | £170.02 m |
---|
Div Yield | 0 | Div per Share | €NaN |
---|
EPS | -€0.20 | Div Cover | NaN |
---|
PEG | n/a | EPS Growth (%) | 0.00 |
---|
ROCE | n/a | DPS Growth (%) | 0 |
---|
Current Ratio | 1.445792 | Quick Ratio | 1.445792 |
---|
Faron Pharmaceuticals Oy Director Deals
Declared | Type | Director | Pos. | Volume / Price | Value |
---|
24/06/24 | TIN | Markku Jalkanen | CEO | 16,667 @ £0.00 | £0.00 |
24/06/24 | TIN | Markku Jalkanen | CEO | 16,667 @ £0.00 | £0.00 |
24/06/24 | TIN | Yrjo Wichmann | RES | 2,333 @ £0.00 | £0.00 |
24/06/24 | TIN | Tuomo Patsi | NED | 6,667 @ £0.00 | £0.00 |
24/06/24 | PLAC | Christine Roth | NED | 46,075 @ €1.00 | €46,075.00 |
09/04/24 | PLAC | Markku Jalkanen | CEO | 33,333 @ £1.50 | £50,000.00 |
09/04/24 | BUY | Markku Jalkanen | CEO | 33,333 @ £1.50 | £50,000.00 |
09/04/24 | PLAC | Tuomo Patsi | NED | 13,333 @ £1.50 | £20,000.00 |
04/04/24 | BUY | Markku Jalkanen | CEO | 33,333 @ £1.50 | £50,000.00 |
04/04/24 | PLAC | Markku Jalkanen | CEO | 33,333 @ £1.50 | £50,000.00 |
More Faron Pharmaceuticals Oy Director Deals >Faron Pharmaceuticals Oy News